Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Sales (2020 - 2025)

Caribou Biosciences has reported Return on Sales over the past 6 years, most recently at 0.07% for Q4 2025.

  • Quarterly Return on Sales rose 11.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, up 3.0% year-over-year, with the annual reading at 0.13% for FY2025, 2.0% up from the prior year.
  • Return on Sales was 0.07% for Q4 2025 at Caribou Biosciences, up from 0.13% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q3 2023 and troughed at 0.19% in Q1 2024.
  • The 5-year median for Return on Sales is 0.09% (2023), against an average of 0.11%.
  • Year-over-year, Return on Sales fell -18bps in 2024 and then increased 11bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.07% in 2021, then dropped by -15bps to 0.08% in 2022, then dropped by -27bps to 0.11% in 2023, then plummeted by -78bps to 0.19% in 2024, then surged by 61bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Return on Sales are 0.07% (Q4 2025), 0.13% (Q3 2025), and 0.18% (Q2 2025).